LFMD Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

3.804

Open

3.750

VWAP

3.63

Vol

944.95K

Mkt Cap

172.71M

Low

3.490

Amount

3.43M

EV/EBITDA(TTM)

62.59

Total Shares

47.97M

135.92M

EV/OCF(TTM)

65.59

P/S(TTM)

0.85

LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.

Events Timeline

(ET)

2026-03-31

07:50:00

New

Novo Nordisk Launches Wegovy Subscription Program, Save Up to $1200 Annually

2026-03-09 (ET)

2026-03-09

16:20:00

LifeMD Sees FY26 Adjusted EBITDA of $12M-$17M

2026-03-09

16:20:00

Company Sees Q1 Adjusted EBITDA Loss of $4M-$5M

2026-03-09

16:20:00

LifeMD Q4 Revenue $46.87M Beats Expectations

2026-01-06 (ET)

2026-01-06

08:50:00

LifeMD Closes $50M Credit Facility with Citizens Bank

News

5.0

03-16seekingalpha

LifeMD Appoints New CFO, Shares Rise 7%

5.0

03-16seekingalpha

LifeMD Appoints New CFO to Support Growth Phase

5.0

03-16NASDAQ.COM

LifeMD Appoints New CFO and Executives

9.5

03-10seekingalpha

LifeMD Stock Soars After Strong Q4 Performance and Upgraded Rating

9.5

03-10Yahoo Finance

LifeMD Reports Strong Q4 and Full Year 2025 Earnings Growth

9.5

03-09seekingalpha

LifeMD, Inc. Reports Strong Q4 2025 Earnings with Positive Outlook

7 Analyst Rating

Wall Street analysts forecast LFMD stock price to rise

6 Buy

1 Hold

0 Sell

Strong Buy

Current: 0.000

Low

6.00

Averages

9.67

High

15.00

Current: 0.000

Low

6.00

Averages

9.67

High

15.00

Mizuho

Neutral -> Outperform

upgrade

$6 -> $8

AI Analysis

2026-03-16

Reason

Mizuho

Price Target

$6 -> $8

AI Analysis

2026-03-16

upgrade

Neutral -> Outperform

Reason

Mizuho upgraded LifeMD to Outperform from Neutral with a price target of $8, up from $6. The firm cites the company's better than expected 2026 outlook for the upgrade. LifeMD continues to expand into new therapeutic areas for virtual care, but the investment thesis is still riven by the company's weight loss management program, the analyst tells investors in a research note. Mizuho sees the company's oral GLP-1 drugs "serving as the anchor" to drive patient growth in 2026 and beyond. It views LifeMD as a "portfolio" play on branded GLP-1s from both Eli Lilly and Novo Nordisk, "without having to decide which manufacturer will be the winner."

Freedom Capital

Buy

upgrade

$8 -> $10

2026-03-12

Reason

Freedom Capital

Price Target

$8 -> $10

2026-03-12

upgrade

Buy

Reason

Freedom Capital raised the firm's price target on LifeMD to $10 from $8 and keeps a Buy rating on the shares. The company's Q4 reported confirm a growth reacceleration as its revenue and adjusted EBITDA beat expectations, the analyst tells investors in a research note. The firm sees share upside from LifeMD's user-retention metrics.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for LFMD

Unlock Now

Valuation Metrics

The current forward P/E ratio for LifeMD Inc (LFMD.O) is -9.78, compared to its 5-year average forward P/E of -19.21. For a more detailed relative valuation and DCF analysis to assess LifeMD Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-19.21

Current PE

-9.78

Overvalued PE

40.63

Undervalued PE

-79.06

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

7.49

Current EV/EBITDA

8.83

Overvalued EV/EBITDA

17.59

Undervalued EV/EBITDA

-2.60

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

1.13

Current PS

0.80

Overvalued PS

1.77

Undervalued PS

0.49

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

give me penny stocks

Intellectia · 42 candidates

Market Cap: 50.00M - 1000.00MRegion: USPrice: $0.50 - $5.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEMonth Price Change Pct: $10.00 - $150.00Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

WTI

W&T Offshore Inc

446.33M

SABR

Sabre Corp

596.71M

SIDU

Sidus Space Inc

188.92M

AIRS

AirSculpt Technologies Inc

190.43M

NRGV

Energy Vault Holdings Inc

636.55M

OLPX

Olaplex Holdings Inc

890.31M

can you limit the choices to only 5 stocks

Intellectia · 724 candidates

Price: <= $10.00Pe Ttm: <= 15Target Price Upside Potential: MoreAbovePrice

Ticker

Name

Market Cap$

FLUX

Flux Power Holdings Inc

31.80M

ORGO

Organogenesis Holdings Inc

487.34M

SGMO

Sangamo Therapeutics Inc

127.97M

AQST

Aquestive Therapeutics Inc

409.93M

TRAW

Traws Pharma Inc

19.42M

BTCS

BTCS Inc

126.36M

pennystocks

Intellectia · 37 candidates

Market Cap: <= 300.00MPrice: <= $5.00Beta: HighRiskWeekly Average Turnover: >= 1,000,000Month Price Change Pct: >= $10.00

Ticker

Name

Market Cap$

ASPN

Aspen Aerogels Inc

295.88M

SLQT

SelectQuote Inc

283.31M

STTK

Shattuck Labs Inc

280.96M

AVIR

Atea Pharmaceuticals Inc

275.01M

JELD

JELD-WEN Holding Inc

258.00M

TYGO

Tigo Energy Inc

243.42M

inom den amerikanska marknaden

Intellectia · 15 candidates

Market Cap: <= 1.50BPrice: <= $25.00Beta: HighRiskRsi 14: <= 45Month Price Change Pct: >= $0.00

Ticker

Name

Market Cap$

Sweetgreen Inc

820.33M

NVX

NOVONIX Ltd

222.62M

LFMD

LifeMD Inc

170.40M

TMCI

Treace Medical Concepts Inc

166.30M

HFFG

Hf Foods Group Inc

116.17M

PYXS

Pyxis Oncology Inc

103.36M

penny stocks wth great potential

Intellectia · 10 candidates

Market Cap: <= 1000.00MPrice: <= $5.00Debt Equity: <= 0.500Weekly Average Turnover: >= 1,000,000Annual Revenue Yoy Growth: >= 15.0%

Ticker

Name

Market Cap$

IOVA

Iovance Biotherapeutics Inc

996.39M

LAB

Standard BioTools Inc

630.69M

NPWR

NET Power Inc

575.35M

DGXX

Digi Power X Inc

201.90M

LFMD

LifeMD Inc

170.40M

TONX

Ton Strategy Co

163.68M

what penny stock to invest in

Intellectia · 12 candidates

Market Cap: <= 1000.00MPrice: <= $5.00Debt Equity: <= 1Weekly Average Turnover: >= 1,000,000Annual Revenue Yoy Growth: >= 15.0%

Ticker

Name

Market Cap$

IOVA

Iovance Biotherapeutics Inc

996.39M

LAB

Standard BioTools Inc

630.69M

NPWR

NET Power Inc

575.35M

DGXX

Digi Power X Inc

201.90M

LFMD

LifeMD Inc

170.40M

TONX

Ton Strategy Co

163.68M

Whales Holding LFMD

Trading Trends

People Also Watch

Frequently Asked Questions

What is LifeMD Inc (LFMD) stock price today?

The current price of LFMD is 3.6 USD — it has decreased -3.23

What is LifeMD Inc (LFMD)'s business?

What is the price predicton of LFMD Stock?

Wall Street analysts forecast LFMD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LFMD is9.67 USD with a low forecast of 6.00 USD and a high forecast of 15.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is LifeMD Inc (LFMD)'s revenue for the last quarter?

LifeMD Inc revenue for the last quarter amounts to 46.87M USD, increased 3.84

What is LifeMD Inc (LFMD)'s earnings per share (EPS) for the last quarter?

LifeMD Inc. EPS for the last quarter amounts to 0.41 USD, decreased -392.86

How many employees does LifeMD Inc (LFMD). have?

LifeMD Inc (LFMD) has 347 emplpoyees as of March 31 2026.

What is LifeMD Inc (LFMD) market cap?

Today LFMD has the market capitalization of 172.71M USD.

LFMD Overview

LFMD Overview

Events Timeline

News

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Related Community Screener

Whales Holding LFMD

Trading Trends

People Also Watch

Frequently Asked Questions

What is LifeMD Inc (LFMD) stock price today?

What is LifeMD Inc (LFMD)'s business?

What is the price predicton of LFMD Stock?

What is LifeMD Inc (LFMD)'s revenue for the last quarter?

What is LifeMD Inc (LFMD)'s earnings per share (EPS) for the last quarter?

How many employees does LifeMD Inc (LFMD). have?

What is LifeMD Inc (LFMD) market cap?